ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00315757
Recruitment Status : Completed
First Posted : April 19, 2006
Last Update Posted : August 8, 2013
Sponsor:
Information provided by (Responsible Party):
Human Genome Sciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2010
  Actual Study Completion Date : October 2010
  Certification/Extension First Submitted : March 30, 2011